News

Alvotech receives EU approval for AVT02

NZCR Supports Covid -19 Vaccination for all New Zealanders.

Lipid and Diabetes Research Group joins the NZCR research family

Drs Christian Schwabe and Dr Chris Wynne are authors of a recent Bevacizumab biosimilar publication.

NZCR CEO receives IQVIA Certificate of Achievement (2020)

Kiwis are being given an opportunity to take part in a trial of a potential new COVID-19 vaccine.

New Zealand is leading the world in a new era of exciting gene research with potential to cure genetic conditions in the future.

When two Stanford University graduates (who would eventually own the United States' biggest vaping company), wanted their prototype tested they came to Christchurch!

A trial conducted at CCST (NZCR) by Dr Martin de Bock, Paediatrician, Otago University researcher could have life changing outcomes for people living with Type 1 diabetes.